Health and Fitness Health and Fitness
Wed, May 26, 2010
[ 03:30 AM ] - Market Wire
A.P. Pharma Announces Changes in Management and H .. ng Consulting Practice to Lead FDA Review Process
[ 03:30 AM ] - Market Wire
MELA Sciences Announces FDA Panel to Review MelaFind(R) PMA Application on August 26, 2010
[ 03:27 AM ] - Market Wire
Interactive Live Chat With Dr. Robin Smith, CEO of NeoStem Scheduled to Be Held This Morning
[ 03:15 AM ] - Market Wire
Medtronic CoreValve® System Shows Long-Term Efficacy and Durability in Pivotal Trial
[ 03:00 AM ] - Market Wire
MIT Contracts OSI Optoelectronics to Manufacture .. he MIT 1000 Rapid Microbial Identification System
[ 03:00 AM ] - Market Wire
Appointment of Stephen Nagler to the Sernova Business Advisory Board
Tue, May 25, 2010
[ 09:44 PM ] - Market Wire
Cobalis Files Form of Order with US Bankruptcy Court Signaling Emergence from Bankruptcy
[ 09:30 PM ] - Market Wire
Edwards Lifesciences Announces Receipt of CE Mark for Pulmonic Transcatheter Valve
[ 06:30 PM ] - Market Wire
St. Jude Medical verpflichtet ersten Patienten fr .. Verwendung fraktioneller Flussreserve bei Patien
[ 04:57 PM ] - Market Wire
KCI presenter la sua gamma completa di prodotti p .. per terapia a pressione negativa in occasione de
[ 04:36 PM ] - Market Wire
Il documento di consenso internazionale offre mag .. amento e la prevenzione delle ulcere da pressione
[ 02:30 PM ] - Market Wire
American HomePatient Establishes June 30, 2010 as Annual Meeting Date
[ 02:28 PM ] - Market Wire
AtriCure Announces June Investor Conference Schedule
[ 02:00 PM ] - Market Wire
NexMed Announces Expansion of Senior Business Development Team
[ 01:58 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. ehalf of Shareholders of Odyssey HealthCare, Inc.
[ 01:30 PM ] - Market Wire
Incyte Appoints Wendy Dixon, Ph.D., to Its Board of Directors
[ 01:21 PM ] - Market Wire
Humana Military Healthcare Services Joins Busines .. to Promote Business Practices in the Global Marke
[ 01:21 PM ] - Market Wire
POZEN Announces Receipt of $20 Million Milestone Payment from AstraZeneca
[ 01:14 PM ] - Market Wire
Impax Laboratories Announces Voting Results from 2010 Annual Meeting of Stockholders
[ 01:08 PM ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Odyssey Healthcare, Inc.
[ 01:01 PM ] - Market Wire
75% of Treatment-Nave Patients with Chronic Hepat .. e) with Telaprevir-Based Treatment in Phase 3 Tri
[ 01:01 PM ] - Market Wire
GTx Announces Top Line Results of Phase III Clini .. ne 20 mg for the Prevention of Prostate Cancer in
[ 11:02 AM ] - Market Wire
St. Jude Medical schrijft eerste patint in klinis .. rzoek naar gebruik Fractional Flow Reserve bij pa
[ 11:01 AM ] - Market Wire
St. Jude Medical inscribe a primer paciente en en .. diar la utilizacin de la tecnologa de reserva fra
[ 11:01 AM ] - Market Wire
St. Jude Medical iscrive il primo paziente alla s .. II per studiare la?uso della tecnologia a riserva
[ 11:00 AM ] - Market Wire
Angiotech';s licensee, Cook Medical, announces si .. percent SFA vessel patency for Zilver(R) PTX(TM)
[ 10:28 AM ] - Market Wire
RPC Director Edward Arquilla, M.D. Ph.D. Passes Away
[ 10:00 AM ] - Market Wire
Clinical Data, Inc. Announces Vilazodone Data Fea .. ychiatric Association and Society of Biological P
[ 09:21 AM ] - Market Wire
Thousands of Psychiatric Solutions, Inc. Workers Wear Yellow to Raise Awareness of Mental Health
[ 07:54 AM ] - Market Wire
Teva to Present at the 2010 Citi Investment Research Global Health Care Conference

Teva to Present at the 2010 Citi Investment Research Global Health Care Conference


Published on 2010-05-25 08:00:31 - Market Wire
  Print publication without navigation


JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 2010 Citi Investment Research Global Health Care Conference with Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd., presenting on Thursday, May 27, 2010 in New York.

What:

 Teva Presentation at the 2010 Citi Investment Research Global Health Care Conference

Who:

 Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.

When:

 Thursday, May 27, 2010 at 2:00PM (ET)

Where:

[ http://www.veracast.com/webcasts/citigroup/hc2010/62210202.cfm ] or [ http://www.tevapharm.com/financial/ ]

How:

Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.

Contributing Sources